Caredx Inc (NASDAQ:CDNA) currently has a daily average trading volume of 998.12K but it saw 1695411 shares traded in last market. With a market cap of 1.07B USD, the company’s current market price of $19.30 came rising about 10.67 while comparing to the previous closing price of $17.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $34.84 and as low as $13.18. In the recent trading on the day, stock has struck highest price mark of $18.12 while lowest mark touched by it was $19.75.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which upgraded the stock as “Equal Weight” in its note to investors issued on January 15, 2025, recommending a price target of between $28 and $24 for it. BTIG Research also issued its recommendations for the stock as it upgraded the price target for the stock is $40.
Over the week, CDNA’s stock price is moving 9.91% up while it is 27.22% when we observe its performance for the past one month. Year-to-date it is -9.86% down and over the past year, the stock is showing an upside performance of 48.35%.
The company is expected to be releasing its next quarterly report on 2025-Apr-29, for which analysts forecasted an EPS of 0.12 while estimate for next year EPS is 0.6. In next quarter, company is expected to be making quarterly sales of $94.72M as analysts are expecting the sales for current fiscal year at $371.02M and seeing the company making $427.89M in sales next year. Moreover, analysts are in estimates of $90.72M for current-quarter revenue.
Currently, Caredx Inc’s total number of outstanding shares is 55.46M with 3.11% of that held by the insiders while 99.34% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 16.99% and return on equity (ROE) at 21.57%. It has a price to earnings ratio (P/E ratio) of 16.75 while having a 116.97 of forward P/E ratio. Stock’s beta reads 2.18. Stock has a price to book (P/B) ratio of 2.82 while price to sale or P/S ratio amounts to 3.10. Its return on asset (ROA) is 14.55% on average.
